Kestra Advisory Services’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
GCL
HI
Kestra Advisory Services's CPRX Position: Q2 2026 in Review
Kestra Advisory Services reduced its Catalyst Pharmaceutical (CPRX) stake by 1.2% in Q2 2026, selling an estimated $14.2K and leaving 39,421 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1678.
Kestra Advisory Services first reported a position in CPRX in Q4 2020 and has held it in 5 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- Kestra Advisory Services held 39,421 shares of Catalyst Pharmaceutical worth $1.24M as of Q2 2026.
- Kestra Advisory Services sold 480 Catalyst Pharmaceutical shares in Q2 2026, an estimated $14.2K.
- Catalyst Pharmaceutical made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1678 holding.
- Kestra Advisory Services first reported a position in Catalyst Pharmaceutical in Q4 2020 and has held it in 5 quarters since.
- 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.